BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trialWeijia Wang, Yong Yuan, Kevin G. Pinz et al.|Annals of the Rheumatic Diseases|2024Cited by 194
Validation of BCMA-CD19 Compound CAR-T Therapy in SLE Overlap Syndrome: Over 1.5-Year Follow-UpMin Wang, Weijia Wang, V. Destéfano et al.|Stem Cell Reviews and Reports|2025Cited by 9
Critical role of ADP-ribose polymerase-1 in lps-induced expression of some inflammatory mediators in primary cultured human peripheral blood mononuclear cellsHuang Dan, Liao Yuhua, Xiaoli Li et al.|Unknown|2007Cited by 0